Accessibility Menu
 
Pluri logo

Pluri

(NASDAQ) PSTI

Current PriceN/A
Market CapN/A
Since IPO (2003)-100%
5 Year-91%
1 Year-21%
1 Month-6%

Pluri Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$1.43M

Net Income (TTM)

$10.35M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pluri

Industry

Biotechnology

Employees

127

CEO

Yaky Yanay, CPA

Headquarters

Haifa, 3508409, IL

PSTI Financials

Key Financial Metrics (TTM)

Gross Margin

36%

Operating Margin

-15%

Net Income Margin

-7%

Return on Equity

1%

Return on Capital

1%

Return on Assets

-62%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$654.00K

Operating Income

$23.33M

EBITDA

$23.33M

Operating Cash Flow

$18.21M

Capital Expenditure

$1.62M

Free Cash Flow

$19.83M

Cash & ST Invst.

$5.89M

Total Debt

$6.76M

Pluri Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$198.00K

+7.0%

Gross Profit

$86.00K

-22.5%

Gross Margin

43.43%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

153

N/A

Net Income

$6.87M

-472.1%

EBITDA

$6.63M

-27.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$2.17M

+60.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$6.14M

+25.3%

Short Term Debt

$712.00K

+19.7%

Return on Assets

-61.65%

N/A

Return on Invested Capital

1.38%

N/A

Free Cash Flow

$5.65M

-1364.4%

Operating Cash Flow

$5.21M

-813.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MGTAMagenta Therapeutics, Inc.
$0.70-7.74%
RNTXRein Therapeutics Inc.
$1.21-6.92%
EYENEyenovia, Inc.
$7.56+3.99%
STSASatsuma Pharmaceuticals, Inc.
$1.10+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.45-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.77+0.05%

Questions About PSTI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.